Antineoplaston Therapy in Treating Patients With Stage IV Lung Cancer

NCT00003491 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Slow accrual

Conditions

Stage IV Lung Cancer

Interventions

DRUG: Antineoplaston therapy (Atengenal + Astugenal)

Sponsor

Burzynski Research Institute